Population
Mice on a high-fat diet
Design
Preclinical
Authors
Loading...
Does not support clinical use; leaves open Smad3 as therapeutic target in human metabolic disease.
Smad3 deficiency protects mice against high-fat diet-induced obesity and insulin resistance, suggesting it as a potential therapeutic target.
Tan et al. (2011) studied this question.